Shanghai Aoqi Pharmaceutical Technology Co., Ltd., established on 2008-07-14, Business scope includes pharmaceuticals,R&D of medical devices,And provide related technology development,technical consulting,Technical Services,Technical Contracting,Technical Training,technology intermediary,technology investment;Class I medical device,thermometer,sphygmomanometer,Magnetic therapy appliance,Medical Absorbent Cotton,Medical absorbent gauze,Medical Hygienic Mask,home blood glucose meter,blood glucose test strips,wheelchair,Sales of medical sterile gauze;Sales of Medical Devices. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Nanjing Fuhai Aosai Pharmaceutical Technology Co., Ltd., established on 2015-04-29, Business scope includes medical technology research and development,technology transfer,technical consulting,Technical Services;Biological product,Pharmaceutical product development;Medical information consultation;Medical device information consultation;drug sales(A license or approval is required to operate).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Xi'an Giant Biogene Technology Co., Ltd. is a Chinese private company located in Xi'an. The firm manufactures bioactive ingredient-based professional skin treatment products. It was founded in 2000.

Asahi Kasei Medical Co. Ltd. engages in the development, manufacture and sale of medical devices. It also engages in the development, manufacture and sale of dialyzers, therapeutic apheresis products, leukocyte reduction filters and virus removal filters. The company was founded on July 24, 1974 and is headquartered in Tokyo, Japan.

Dongguan Minghao Qihua Biotechnology Co., Ltd., established on 2012-06-26, Business scope includes biotechnology research and development and technology transfer;Sales,online sale:Health Supplies;wholesale,retail:Pre-packaged food;Health Advisory;Business Consulting;Import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hefei Qixing Pharmaceutical Technology Co., Ltd., established on 2003-03-18, Business scope includes pharmaceuticals,Healthy food,food research and development,Technology transfer and service.

Suzhou He Aode Biomedical Technology Co., Ltd., established on 2015-05-14, Business scope includes biomedical technology development,transfer,consultation service,Medical information consultation,Medical device information consultation.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Haiosi Biomedical Technology Co., Ltd., established on 2015-04-29, Business scope includes biotechnology research and development,technical consulting,Technical Services;Self-operated and agent import and export business of various commodities and technologies.(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Union Pharmaceutical Factory is a private company headquartered in China that manufactures pharmaceutical products.

Shanghai Aiqi Ecological Technology Co., Ltd., established on 1997-08-26, The scope of business includes engaging in ecological and environmental protection,Biotechnology,new building materials,Technology development in the field of computer software and hardware technology,technology transfer,Technical Services,Green facilities,Sales of building materials. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

AnorMED, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic drugs for the treatment of hematology, human immunodeficiency virus (HIV), and oncology. Its lead drug product candidate include MOZOBIL, which is under phase III clinical trial is used for cancer patients undergoing stem cell transplantation; and AMD070, which is under phase Ib/IIa trial is used as a HIV entry inhibitor.

The Group's principal activity is to produce pharmaceuticals and chemicals. The operations are carried out through the following divisions: Pharmaceuticals; Bio chemical; Chemicals; Food and Other. Pharmaceuticals include ethical drugs, bulk pharmaceuticals and biological research. Bio chemicals deal with biochemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemicals includes solvents, plasticizes and their raw materials, detergent raw materials and specialty chemicals. Food includes alcoholic beverages, alcohol, seasonings, confectionery, baking ingredients and processed foods. Others include wholesale, commodity distribution and installation of facilities.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Suntory Holdings Ltd. operates as a holding company with interests in the production and distribution of alcoholic and non-alcoholic beverages, health, beauty, and processed food products. Its services include formulation and promotion of group wide management strategies and corporate functions; sale of alcoholic beverages such as whiskey, beer, and wine; soft drinks; and other beverages such as tea and canned coffee. The company was founded by Shinjiro Torii in 1899 and is headquartered in Osaka, Japan.

Asahi Kasei Pharma Corp., a subsidiary of Asahi Kasei Corp., is a company headquartered in Tokyo, Japan, that functions as an alternative investment manager. The firm was founded in 2003.\nThe company says this about itself: Asahi Kasei Pharma Corporation, headquartered in Tokyo, Japan, is a research-based health care innovator that discovers, develops, manufactures, and markets pharmaceuticals and diagnostic products. Asahi Kasei Pharma is a wholly owned business unit of Asahi Kasei Corporation, a US $20 billion technology company, that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics.

Guangzhou Shaai Biotechnology Co., Ltd., established on 2014-09-12, The scope of business includes the research and development of biological diagnostic reagents and kits(Does not include license approval items);Sales of biological diagnostic reagents and kits(Does not include license approval items);Operation of non-licensed medical devices;Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals);Technology Import and Export;Marketing Planning Service;Advertising;Gene drug development;Stem Cell Technology Research,to develop;Stem Cell Drug Development;Biomedical Technology Research;Biotechnology Extension Services;Health Sciences Program Research,to develop;Health Sciences Program Research Transfer;Technology Promotion of Research Results of Health Science Projects;Human Science Research Achievement Transfer Service;drug development;hospital management;Science and Technology Information Consulting Services;Import and export(Excluding franchised products);collection of stem cells,storage,preparation service(Without umbilical cord blood hematopoietic stem cell collection,storage);Collection of immune cells,storage,preparation service(Without umbilical cord blood hematopoietic stem cell collection,storage);Sales of stem cell engineering series products;Sales of stem cell series technical engineering products;Sales of cell preparations and related products

Part of Meditech Global Group Ltd., Shanghai Bai Sui Hang Pharmaceutical Co. Ltd. is a company headquartered in Shanghai, China, that manufactures pharmaceuticals and health food products. It was acquired by Beijing Jingjing Medical Equipment Co., Ltd. on December 22, 2004 for $0.36 million.

Shanghai Guangfeng Biotechnology Co., Ltd., established on 2009-09-11, Business scope includes licensed projects:Class III medical device business;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Business Management Consulting;Information Consulting Service(Not including licensing information consulting services);Sales of Class I Medical Devices;Sales of Class II Medical Devices;Auto Parts Retail;Sales of electronic components and electromechanical components;Hardware retail;Sales of building materials;electronics sales;Office Supplies Sales;General merchandise sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)